Skip to main content

Table 2 Data comparing high and low cumulative anthracycline dose.

From: Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques: probing the pathology

CARDIOVASCULAR MR DATA

Low dose <300mg/m2 (n =22)

High dose >300mg/m2 (n = 8)

p Value

LVEDV index (ml/m2)

71 ±11

80 ±14

0.1

LVESV index (ml/m2)

28 ±8

36 ±6

*0.03

LV EF (%)

65 ±5

54 ±6

*0.01

LV Mass index (g/m2)

58 ±11

59 ±9

0.94

RVEDV index (ml/m2)

70 ±10

69 ±17

0.87

RVESV index (ml/m2)

28 ±15

26 ±7

0.77

RV EF (%)

65 ±5

62 ±2

0.46

MAPSE (cm)

13 ±2.1

13 ±4.1

0.72

Left Atrial Area (cm2)

21 ±3

21 ±4

0.94

Native T1

960 ±39

992 ±24

*0.05

Native blood pool T1

1464 ±79

1527±38

*0.05

Extracellular volume fraction

0.25 ±0.02

0.28 ±0.05

*0.02

LGE

1 (14)

1 (5)

 
  1. Values expressed mean mean ±SD
  2. LVEDV = left ventricular end diastolic volume; LVESV = left ventricular end systolic volume; LVEF = left ventricular ejection fraction; RVEDV = right ventricular end diastolic volume; RVESV = right ventricular end systolic volume; RVEF = right ventricular ejection fraction; MAPSE = mitral annular plane systolic excursion; LGE = Late gadolinium enhancement